Literature DB >> 8044774

Allelotype of endometrial carcinoma.

T Fujino1, J I Risinger, N K Collins, F S Liu, H Nishii, H Takahashi, E M Westphal, J C Barrett, H Sasaki, M F Kohler.   

Abstract

An allelotype analysis of endometrial carcinoma was undertaken to identify chromosomal loci that are relevant to this tumor type. A total of 70 highly polymorphic microsatellite markers, distributed among all nonacrocentric chromosome arms, were examined for evidence of loss of heterozygosity or allelic imbalance in DNA samples from matched normal and tumor tissues. An average of 21 informative tumor cases were obtained for each marker. Allelic deletions or imbalance were observed on 31 of 41 chromosome arms with no marker showing an allelic loss ratio of greater than 33%. Those chromosome arms most frequently involved were 3p, 8p, 9p, 14q, 16q and 18q. There was a strong correlation between loss of heterozygosity on chromosome 14q and death from disease. These data indicate that the molecular genetic character of endometrial carcinoma is complex and that a relatively large number of different chromosomal loci are likely to play a role in the etiology and progression of this tumor type.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8044774

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 2.  Inactivation of X-linked tumor suppressor genes in human cancer.

Authors:  Runhua Liu; Mandy Kain; Lizhong Wang
Journal:  Future Oncol       Date:  2012-04       Impact factor: 3.404

Review 3.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

Review 4.  Frizzled homolog proteins, microRNAs and Wnt signaling in cancer.

Authors:  Koji Ueno; Hiroshi Hirata; Yuji Hinoda; Rajvir Dahiya
Journal:  Int J Cancer       Date:  2012-08-30       Impact factor: 7.396

5.  Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer.

Authors:  Anna Torres; Kamil Torres; Tomasz Paszkowski; Barbara Jodłowska-Jędrych; Tomasz Radomański; Andrzej Książek; Ryszard Maciejewski
Journal:  Tumour Biol       Date:  2011-05-11

6.  Deletion mapping on chromosome 10q25-q26 in human endometrial cancer.

Authors:  S Nagase; S Sato; F Tezuka; Y Wada; A Yajima; A Horii
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

7.  Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, Ishikawa.

Authors:  S Takeda; W P Soutter; N J Dibb; J O White
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

8.  Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.

Authors:  J K Field; H Kiaris; J M Risk; C Tsiriyotis; R Adamson; V Zoumpourlis; H Rowley; K Taylor; J Whittaker; P Howard
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

9.  Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance.

Authors:  Maryam K Mohammed; Connie Shao; Jing Wang; Qiang Wei; Xin Wang; Zachary Collier; Shengli Tang; Hao Liu; Fugui Zhang; Jiayi Huang; Dan Guo; Minpeng Lu; Feng Liu; Jianxiang Liu; Chao Ma; Lewis L Shi; Aravind Athiviraham; Tong-Chuan He; Michael J Lee
Journal:  Genes Dis       Date:  2016-01-14

10.  Dicer Gene Expression as a Prognostic Factor in Acute Lymphoblastic Leukemia and Chronic Lymphocytic Leukemia in Fars Province.

Authors:  Mohamad Reza Farzaneh; Jahanbanoo Shahryari; Akbar Safaei; Behnaz Valibeigi; Shahrbanou Karimi Davani; Narjes Tabibi
Journal:  Iran J Med Sci       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.